Exercise capacity, muscle strength, dyspnea, physical activity, and quality of life in preoperative patients with lung cancer

Exercise capacity, muscle strength, dyspnea, physical activity, and quality of life in preoperative patients with lung cancer

Background/aim: To detect the extent to which physical impairments are observed in patients with lung cancer awaiting lung surgery, exercise capacity, muscle strength, physical activity, dyspnea, and quality of life (QOL) were objectively compared between the patients and healthy individuals in current study. Materials and methods: Patients with lung cancer (n = 26) and healthy individuals (n = 21) were included. Exercise capacity, respiratory (maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP)) and quadriceps femoris muscle strength, physical activity, dyspnea and QOL were evaluated using 6-min walk test (6-MWT), a mouth pressure device, a hand-held dynamometer, a metabolic holter device, Modified Medical Research Council dyspnea scale and European Organization for Research and Treatment of Cancer QOL Questionnaire C30 version 3.0, respectively. Results: The 6-MWT distance (mean difference: 78.97 m), percentages of predicted MIP and MEP values, physical activity parameters (energy expenditures, physical activity duration, average metabolic equivalent and number of steps) and QOL subscales scores (functional, social function and global health status) were significantly lower in the patients than healthy individuals (p < 0.05). Dyspnea perception and other QOL subscales scores (symptom and fatigue) were significantly higher in patients than healthy individuals (p < 0.05). No significant difference was prevalent in quadriceps femoris muscle strength (p > 0.05). Sixteen (66.7%) patients were sedentary. Conclusion: Severe reductions in exercise capacity, respiratory muscle strength, and physical activity level, poorer QOL and evident dyspnea exist in preoperative patients with lung cancer. Therefore, patients should be included in early protective rehabilitation program including aerobic exercise, respiratory muscle training and physical activity counseling before lung surgery.Key words: Lung neoplasms, walk test, dyspnea, muscle strength, exercise, quality of life

___

  • 1. Pinson P, Klastersky J. The value of lung function measurements for the assessment of chemotherapy in lung cancer patients. Lung Cancer: Journal of The International Association for The Study of Lung Cancer 1998; 19 (3): 179-184. doi: 10.1016/ s0169-5002(97)00094-9
  • 2. Granger CL, McDonald CF, Irving L, Clark RA, Gough K et al. Low physical activity levels and functional decline in individuals with lung cancer. Lung Cancer: Journal of The International Association for The Study of Lung Cancer 2014; 83 (2): 292-299. doi: 10.1016/j.lungcan.2013.11.014
  • 3. Nomori H, Horio H, Fuyuno G, Kobayashi R, Yashima H. Respiratory muscle strength after lung resection with special reference to age and procedures of thoracotomy. European Journal of Cardio-Thoracic Surgery: Official Journal of The European Association for Cardio-thoracic Surgery 1996; 10 (5): 352-358. doi: 10.1016/s1010-7940(96)80094-7
  • 4. Weiner P, Man A, Weiner M, Rabner M, Waizman J et al. The effect of incentive spirometry and inspiratory muscle training on pulmonary function after lung resection. The Journal of Thoracic and Cardiovascular Surgery 1997; 113 (3): 552-557. doi: 10.1016/S0022-5223(97)70370-2
  • 5. Bower JE. Cancer-related fatigue—mechanisms, risk factors, and treatments. Nature reviews. Clinical oncology 2014; 11 (10): 597-609. doi: 10.1038/nrclinonc.2014.127
  • 6. Fox SW, Lyon DE. Symptom clusters and quality of life in survivors of lung cancer. Oncology Nursing Norum 2006; 33 (5): 931-936. doi: 10.1188/06.ONF.931-936
  • 7. Lin S, Chen Y, Yang L, Zhou J. Pain, fatigue, disturbed sleep and distress comprised a symptom cluster that related to quality of life and functional status of lung cancer surgery patients. Journal of Clinical Nursing 2013; 22 (9-10): 1281-1290. doi: 10.1111/jocn.12228
  • 8. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 2002; 166 (1): 111-117. doi: 10.1164/ajrccm.166.1.at1102
  • 9. Gibbons WJ, Fruchter N, Sloan S, Levy RD. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. Journal of Cardiopulmonary Rehabilitation 2001; 21 (2): 87-93. doi: 10.1097/00008483-200103000-00005
  • 10. American Thoracic Society/European Respiratory Society. ATS/ERS statement on respiratory muscle testing. American Journal of Respiratory and Critical Care Medicine 2002; 166 (4): 518-624. doi: 10.1164/rccm.166.4.518
  • 11. Evans JA, Whitelaw WA. The assessment of maximal respiratory mouth pressures in adults. Respiratory Care 2009; 54 (10): 1348-1359.
  • 12. Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with handheld dynamometers. Physical Therapy 1996; 76 (3): 248-259. doi: 10.1093/ptj/76.3.248
  • 13. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2005; 171 (9): 972-977. doi: 10.1164/rccm.200407-855OC
  • 14. Tudor-Locke C, Bassett Jr DR. How many steps/day are enough? Preliminary pedometer indices for public health. Sports Medicine 2004; 34 (1): 1-8. doi: 10.2165/00007256- 200434010-00001
  • 15. Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett Jr DR et al. 2011 Compendium of physical activities: a second update of codes and MET values. Medicine and Science in Sports and Exercise 2011; 43 (8): 1575-1581. doi: 10.1249/ mss.0b013e31821ece12
  • 16. Stenton C. The MRC dyspnoea scale. Occupational Medicine 2008; 58 (3): 226-227. doi: 10.1093/occmed/kqm162
  • 17. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of The National Cancer Institute 1993; 85 (5): 365-376. doi: 10.1093/ jnci/85.5.365
  • 18. Hummler S, Thomas M, Hoffmann B, Philipp Gärtner, Martin Zoz et al. Physical performance and psychosocial status in lung cancer patients: results from a pilot study. Oncology Research and Treatment 2014; 37 (1-2): 36-41. doi: 10.1159/000358157
  • 19. Brocki BC, Westerdahl E, Langer D, Souza DS, Andreasen JJ. Decrease in pulmonary function and oxygenation after lung resection. ERJ Open Research 2018; 4 (1): 00055-2017. doi: 10.1183/23120541.00055-2017
  • 20. Morano MT, Araújo AS, Nascimento FB, Silva GF, Mesquita R et al. Preoperative pulmonary rehabilitation versus chest physical therapy in patients undergoing lung cancer resection: a pilot randomized controlled trial. Archives of Physical Medicine and Rehabilitation 2013; 94 (1): 53-58. doi: 10.1016/j. apmr.2012.08.206
  • 21. Pehlivan E, Balcı A, Kılıç L. Can functional inoperability in lung cancer patients be changed by pulmonary rehabilitation? Türk Göğüs Kalp Damar Cerrahisi Dergisi 2019; 27 (2): 212- 218. doi: 10.5606/tgkdc.dergisi.2019.16474
  • 22. Ha D, Ries AL, Lippman SM, Fuster MM. Effects of curativeintent lung cancer therapy on functional exercise capacity and patient-reported outcomes. Supportive Care in Cancer 2020; 28 (10): 4707-4720. doi: 10.1007/s00520-020-05294-3
  • 23. Nomori H, Kobayashi R. Postoperative pulmonary complications in patients undergoing thoracic surgery with special reference to preoperative respiratory muscle strength and nutrition. [Zasshi] [Journal] 1994; 42 (9): 1272-1275.
  • 24. Avancini A, Sartori G, Gkountakos A, Casali M, Trestini I et al. Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled? The Oncologist 2020; 25 (3): e555-569. doi: 10.1634/theoncologist.2019-0463
  • 25. Nishimura JM, Ansari AZ, D’Souza DM, Moffatt-Bruce SD, Merritt RE et al. Computed tomography-assessed skeletal muscle mass as a predictor of outcomes in lung cancer surgery. The Annals of Thoracic Surgery 2019; 108 (5): 1555-1564. doi: 10.1016/j.athoracsur.2019.04.090
  • 26. Naito T, Okayama T, Aoyama T, Ohashi T, Masuda Y et al. Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non–small-cell lung cancer. BMC Cancer 2017; 17 (1): 571. doi: 10.1186/s12885-017-3562-4
  • 27. Schneider CM, Hsieh CC, Sprod LK, Carter SD, Hayward R. Cancer treatment-induced alterations in muscular fitness and quality of life: the role of exercise training. Annals of oncology : official journal of the European Society for Medical Oncology/ ESMO 2007; 18 (12): 1957-1962. doi: 10.1093/annonc/ mdm364
  • 28. Edbrooke L, Granger CL, Clark RA, Denehy L. Physical Activity Levels Are Low in Inoperable Lung Cancer: Exploratory Analyses from a Randomised Controlled Trial. Journal of Clinical Medicine 2019; 8 (9): 1288. doi: 10.3390/jcm8091288
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Dual energy CT in necrotizing enterocolitis; a novel diagnostic approach

Mustafa KARA, Özgür ÇAĞLAR, Binali FIRINCI, Mehmet Emin ÇELİKKAYA, Recep SADE, Emrullah CESUR, Akgün ORAL, Murat YİĞİTER, Sevilay ÖZMEN

Antiinflammatory effects of adalimumab, tocilizumab, and steroid on lipopolysaccharide-induced lung injury

Fatma Bahar SUNAY, Mehmet KÖSE, Nurhan SARIOĞLU, Fuat EREL, Oğuzhan KORKUT, Adnan Adil HİŞMİOĞULLARI, Arzu YAY, Betül YALÇIN

Risk of autism spectrum disorder in children with a history of hospitalization for neonatal jaundice

Ayla UZUN ÇİÇEK, Gaffari TUNÇ, Fatih KILIÇBAY

Assessment of olfactory and gustatory functions in COVID-19 patients

https://orcid.org/0000-0001-9112-3986, Mehmet DÜZLÜ, Alper CEYLAN, Hakan TUTAR, Süleyman CEBECİ, Muammer Melih ŞAHİN, Murat DİZBAY, Eray UZUNOĞLU, Mücahit YALÇIN, Gökçen CESUR, Mehmet YILDIZ, Hasan Selçuk ÖZGER, Pınar AYSERT YILDIZ

Interleukin-21: a potential biomarker for diagnosis and predicting prognosis in COVID-19 patients

Aslı GÖREK DİLEKTAŞLI, Ezgi DEMİRDÖĞEN, Mehmet KARADAĞ, Ayşe Esra UZASLAN, Ahmet URSAVAŞ, Dane EDİGER, Haluk Barbaros ORAL, Nilüfer Aylin ACET ÖZTÜRK, Necmiye Funda COŞKUN, Diğdem YÖYEN ERMİŞ, Mert KARACA, Shahriyar MAHARRAMOV, Gamze YAZICI

Assessment of fragmented QRS formation and its relationship with left ventricular hypertrophy in nonhypertensive acromegaly patients

Kadir Uğur MERT, Göknur YORULMAZ, Selda MURAT, Muhammet DURAL, Elif Sevil ALAGÜNEY, Ahmet Serdar YILMAZ, Nur KEBAPÇI, Ezgi CAMLI, Belgin EFE, Aysen AKALIN, Ahmet Toygar KALKAN

Assessment of erythrocyte morphology in patients with type 2 diabetes mellitus: a pilot study of electron microscopy-based analysis in relation to healthy controls

Şenay ARIKAN DURMAZ, Tülay MORTAŞ, Şaban Cem SEZEN, Yasemin SAVRANLAR

The role of gold weight implants in the management of paralytic lagophthalmos

Recep KARAMERT, Mehmet DÜZLÜ, Alper CEYLAN, Hakan TUTAR, Süleyman CEBECİ, Muammer Melih ŞAHİN, Eray UZUNOĞLU, Mücahit YALÇIN, Gökçen CESUR, Mehmet Birol UĞUR

Quantitative analysis of distal femoral epiphysis blood supply in healthy infants with superb microvascular imaging: a pilot study

Mehmet ÖZTÜRK, Emine ÇALIŞKAN, Hatice ARIÖZ HABİBİ, Muhammed Samed CANSIZ

Mean platelet volume in familial Mediterranean fever related AA amyloidosis and comparison with common primary glomerular diseases

Rahmi YILMAZ, Emine Arzu AYHAN, Neriman Sıla KOÇ, Tolga YILDIRIM, Yunus ERDEM, Müge ÜZERK KİBAR, Berranur KÜTAHYA, Fatma İŞ, Mehmet ERDEVİR